Literature DB >> 3688779

Cytostatic extravasations.

P Preuss1, S Partoft.   

Abstract

Sixty-six cases of cytostatic extravasation referred to a plastic surgery department between 1977 and mid-1985 are discussed. Doxorubicin was the most common drug involved, but a number of other drugs also caused lesions requiring surgical intervention. Operative treatment, consisting of excision of drug-infiltrated tissue followed by skin transplantation, was performed in half the patients. Significant residual damage was seen in 12 patients who had all received the drug at the elbow joint, wrist, or back of the hand. Fourteen patients were operated on late in the course of the disease, on average 10 weeks after the accident because of delayed referral. In 1983 prophylaxis was undertaken and first-aid treatment was administered, consisting of aspiration via the administration catheter. The nature of patient referrals then improved considerably. It is recommended that cytostatic treatment be given at the antebrachium, if possible, and that aspiration be attempted promptly after an accident. Manifest lesions should be operated on early, i.e., within the first week. The indication for early operation is particularly strong if a highly irritative drug has been deposited in a critical region and has caused a severe local reaction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3688779     DOI: 10.1097/00000637-198710000-00005

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  8 in total

Review 1.  Extravasation of chemotherapy.

Authors:  Seppo W Langer
Journal:  Curr Oncol Rep       Date:  2010-07       Impact factor: 5.075

Review 2.  [Antineoplastic drug-induced extravasation].

Authors:  Maike de Wit
Journal:  Med Klin (Munich)       Date:  2010-11

3.  Local granulocyte-macrophage colony-stimulating factor improves incisional wound healing in adriamycin-treated rats.

Authors:  Mehmet Ali Gulcelik; Soykan Dinc; Meral Dinc; Erdinc Yenidogan; Huseyin Ustun; Nurten Renda; Haluk Alagol
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Combined management in the treatment of epidoxorubicin extravasation. A case report.

Authors:  D Dini; G Forno; A Gozza; S Silvestro; G Bertelli; S Toma; F Filippi; B Passarelli
Journal:  Support Care Cancer       Date:  1995-03       Impact factor: 3.603

Review 5.  Prevention and management of extravasation of cytotoxic drugs.

Authors:  G Bertelli
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

Review 6.  [Extravasation of cytotoxic agents].

Authors:  Elisabeth Nogler-Semenitz; Ines Mader; Patrizia Fürst-Weger; Robert Terkola; Sabine Wassertheurer; Pietro Giovanoli; Robert M Mader
Journal:  Wien Klin Wochenschr       Date:  2004-05-31       Impact factor: 1.704

7.  Anthracycline extravasation injuries: management with dexrazoxane.

Authors:  Karin Jordan; Timo Behlendorf; Franziska Mueller; Hans-Joachim Schmoll
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

Review 8.  Dexrazoxane for the treatment of chemotherapy-related side effects.

Authors:  Seppo W Langer
Journal:  Cancer Manag Res       Date:  2014-09-15       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.